HSIC's growth from its Henry Schein One venture and partnerships is promising, but macro pressures and stiff competition ...

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some ...

With a market cap of $8.5 billion, Henry Schein, Inc. (HSIC) is a global healthcare distribution and solutions company ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein (NASDAQ:HSIC) in the last three months. The table below offers a condensed view of ...

Henry Schein (NASDAQ:HSIC) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Henry Schein, Inc. is rated a Buy as signs of improving growth and undervaluation emerge despite recent stagnation. Click for ...

Management reaffirmed its 2025 guidance, projecting non-GAAP diluted EPS to be between $4.80 and $4.94, with growth expected to be more weighted toward the second half of the year. Total sales growth ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...

Detailed price information for Henry Schein Inc (HSIC-Q) from The Globe and Mail including charting and trades.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the ...

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's ...